Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
- PMID: 26985178
- PMCID: PMC4793053
- DOI: 10.5114/pdia.2015.48039
Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
Abstract
Introduction: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions.
Aim: Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures.
Material and methods: We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000-2012.
Results: In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%.
Conclusions: Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method.
Keywords: Ki-67 antigen; eyelid; recurrent BCC.
Figures
Similar articles
-
Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.Acta Dermatovenerol Alp Pannonica Adriat. 2011 Jun;20(2):67-75. Acta Dermatovenerol Alp Pannonica Adriat. 2011. PMID: 21993704
-
Histological and clinical features of primary and recurrent periocular Basal cell carcinoma.ISRN Ophthalmol. 2012 Apr 24;2012:354829. doi: 10.5402/2012/354829. eCollection 2012. ISRN Ophthalmol. 2012. PMID: 24555125 Free PMC article.
-
Management of periocular basal and squamous cell carcinoma: a series of 485 cases.Am J Ophthalmol. 2006 Aug;142(2):293-7. doi: 10.1016/j.ajo.2006.03.055. Am J Ophthalmol. 2006. PMID: 16876511
-
[Periocular basal cell carcinoma].Arch Soc Esp Oftalmol. 2005 May;80(5):275-82. Arch Soc Esp Oftalmol. 2005. PMID: 15918094 Review. Spanish.
-
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.Br J Dermatol. 2004 Jul;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. Br J Dermatol. 2004. PMID: 15270883 Review.
Cited by
-
Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):96-102. doi: 10.4103/meajo.MEAJO_305_17. Middle East Afr J Ophthalmol. 2018. PMID: 30122855 Free PMC article.
-
Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases.J Skin Cancer. 2022 Feb 18;2022:4075668. doi: 10.1155/2022/4075668. eCollection 2022. J Skin Cancer. 2022. PMID: 35223100 Free PMC article.
-
Periocular basal cell carcinoma: recurrence risk factors/when to reoperate?Postepy Dermatol Alergol. 2020 Dec;37(6):927-931. doi: 10.5114/ada.2020.102109. Epub 2021 Jan 6. Postepy Dermatol Alergol. 2020. PMID: 33603611 Free PMC article.
-
Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?Postepy Dermatol Alergol. 2017 Dec;34(6):607-611. doi: 10.5114/ada.2017.72467. Epub 2017 Dec 31. Postepy Dermatol Alergol. 2017. PMID: 29422827 Free PMC article.
-
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment.Onco Targets Ther. 2017 May 8;10:2483-2489. doi: 10.2147/OTT.S130371. eCollection 2017. Onco Targets Ther. 2017. PMID: 28507440 Free PMC article. Review.
References
-
- Coroi M, Rosca E, Mutiu G, et al. Eyelid tumors: histopathological study performed in County Hospital of Oradea between 2000-2007. Rom J Morphol Embryol. 2010;51:111–5. - PubMed
-
- Zieliński T, Pisera P, Siewiera I, et al. Chirurgiczne leczenie złośliwych nowotworów powiek. Pol Merk Lek. 2013;34:214–8. - PubMed
-
- Zieliński T, Iljin A, Antoszewski B. Nowotwory złośliwe powiek – wyniki leczenia chirurgicznego i wybór metody rekonstrukcji. Nowotwory J Oncol. 2012;62:431–7.
-
- Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies. Ophthalmology. 2001;108:2089–98. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources